Ceradyne Inc - Current report filing (8-K)
February 04 2008 - 5:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 31, 2008
CERADYNE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation)
|
|
000-13059
(Commission File Number)
|
|
33-0055414
(IRS Employer Identification No.)
|
|
|
|
3169 Red Hill Avenue, Costa Mesa, CA
(Address of principal executive offices)
|
|
92626
(Zip Code)
|
Registrants telephone number, including area code: (714) 549-0421
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
|
|
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit Index on page 4
TABLE OF CONTENTS
|
|
|
Item 7.01
|
|
Regulation FD Disclosure.
|
On January 31, 2008, Ceradyne, Inc. issued a press release announcing that it has received a
$59.1 million body order for Enhanced Side Ballistic Inserts (ESBI) body armor from the U.S. Army,
Aberdeen Proving Ground, Maryland. A copy of this press release is being furnished as Exhibit 99.1
to this Current Report on Form 8-K.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report
on Form 8-K, including Exhibit 99.1, shall not be deemed filed for the purposes of Section 18 of
the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
|
|
|
Item 9.01
|
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
|
|
Exhibit Number
|
|
Description
|
99.1
|
|
Press release of Ceradyne, Inc. dated January 31, 2008.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
CERADYNE, INC.
|
|
February 4, 2008
|
By:
|
/s/ Jerrold J. Pellizzon
|
|
|
|
Jerrold J. Pellizzon
|
|
|
|
Chief Financial Officer and Secretary
|
|
|
3
EXHIBIT INDEX
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
99.1
|
|
Press release of Ceradyne, Inc. dated January 31, 2008.
|
4
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From May 2024 to Jun 2024
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jun 2023 to Jun 2024